
About Caventis
Caventis is a Healthcare company based in Delhi (India) founded in 2012. It manufactures and markets generic medicines including tablets, capsules, and syrups across India. It operates on a B2B and Franchise model. Its Indian entity Caventis Pharma Private Limited reported revenue of βΉ4.88 Cr. Caventis offers products and services including Tablets, Capsules/Softgels, Dry Syrups, Eye/Ear Drops, and Injectables. Its focus areas include Pharmaceuticals, Generic Drugs, Medicines Distribution and Over-the-Counter. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.
Company details
Caventis Pharma Private Limited is a fast-growing generic pharmaceutical company headquartered in Delhi, India. It offers a wide range of products such as tablets, capsules, syrups, and injectables through a network of over 50 distributors and 4000 stockists. The company focuses on providing international quality medicines at affordable prices, adhering to WHO guidelines, and aims to serve consumers nationwide with high-quality healthcare solutions.
- Headquarters Delhi, India
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website caventis.com
- Legal Name Caventis Pharma Private Limited
- Date of Incorporation 22 Aug, 2012
- Jurisdiction Delhi, India
- Annual Revenue₹4.88 Cr
FY 2024 · -11% YoY
- Net Profit₹7.1 Lakh
FY 2024 · 1% margin
- EBITDA₹33 Lakh
FY 2024 · 7% margin
Associated legal entities of Caventis
Caventis operates through Caventis Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Caventis Pharma Private Limited CIN U51909DL2012PTC240513 | Active | 22 Aug 2012 | Delhi, Delhi | ₹4.9 Cr | 2 | View details |
Products & Services of Caventis
Caventis offers a comprehensive portfolio of products and services, including Tablets, Capsules/Softgels, Dry Syrups, Eye/Ear Drops, and Injectables.
Oral tablets for treating various health conditions and diseases.
Encapsulated medicines for targeted health benefits and easy consumption.
Powder-based syrups for pediatric and adult use in infection treatments.
Drops for eye and ear infections to provide quick relief and care.
Injectable forms for rapid administration in medical emergencies.
Board of directors of Caventis Pharma Private Limited (Caventis)
Caventis Pharma Private Limited is the primary company behind Caventis. The board of Caventis Pharma Private Limited currently have 2 directors; the longest-serving is Kushal Agrawal, appointed in 2013. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kushal Agrawal DIN 03520935 | Director | 19 Sep 2013 | 13 yrs 2 mo | Caventis Pharma Private Limited |
| Ketan Agrawal DIN 06729861 | Director | 22 Oct 2018 | 8 yrs | Caventis Pharma Private Limited |
Financials of Caventis
Figures of Caventis Pharma Private Limited, the primary company behind Caventis, for FY 2024. Revenue was ₹4.88 Cr (-11% year on year). Net profit was ₹7.1 Lakh (1% margin). EBITDA was ₹33 Lakh (7% margin). Revenue has grown at a compounded annual rate of -14% over three years and -5% over five years.
- ₹4.88 CrRevenue · FY 2024 · -11% YoY
- ₹7.1 LakhNet profit · 1% margin
- ₹33 LakhEBITDA · 7% margin
- ₹1 LakhPaid-up capital
- -14%Revenue CAGR, 3 years
- -5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Caventis Pharma Private Limited are on its company page.
Detailed financial statements for Caventis
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Caventis
Caventis has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $8.98M | 161 | Provider of medical equipment, devices, and drugs distribution services |
Detailed similar companies of Caventis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Caventis
Caventis was founded in 2012.
Caventis is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
The primary company behind Caventis, Caventis Pharma Private Limited, reported revenue of βΉ4.88 Cr for FY 2024, down 11% year on year.
Caventis Pharma Private Limited is a fast-growing generic pharmaceutical company headquartered in Delhi, India. It offers a wide range of products such as tablets, capsules, syrups, and injectables through a network of over 50 distributors and 4000 stockists. The company focuses on providing international quality medicines at affordable prices, adhering to WHO guidelines, and aims to serve consumers nationwide with high-quality healthcare solutions.
Caventis's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.
Caventis offers Tablets, Capsules/Softgels, Dry Syrups, Eye/Ear Drops, and Injectables.
Caventis operates through Caventis Pharma Private Limited.
The legal entities of Caventis currently have 2 directors, including Kushal Agrawal, Ketan Agrawal.